The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global downstream processing market is expected to exhibit a CAGR of 14.67% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Downstream processing refers to the purification and recovery of biosynthetic and pharmaceutical products extracted from natural sources. The sources include plant and animal tissues that can be recycled and treated. Downstream processing involves solid-liquid separation, release of intracellular products, chromatography purification and formulation. These processes are conducted through floatation, flocculation, centrifugation and filtration and are used for the manufacturing of anti-infection agents, antibiotics, antibodies, hormones, vaccines and industrial enzymes. Downstream processing also aids in maximizing product recovery and minimizing the overall cost of production.
Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. Downstream processing is widely used for isolating, purifying and concentrating the synthesized drug substances from the complex bulk matrix. Furthermore, the increasing prevalence of various infectious diseases, such as dengue, hepatitis and swine influenza, is providing a thrust to the market growth. As the coronavirus disease (COVID-19) continues to spread, there has been a substantial increase in the utilization of downstream processing for the manufacturing of vaccines with higher efficacy and minimal side-effects. Additionally, various technological advancements, such as the development of innovative multicomponent separation and perfusion chromatography systems, are acting as other growth-inducing factors. These solutions are widely utilized for the purification of recombinant protein produced by animal cell cultures to create high-value products. Other factors, including extensive research and development (R&D) activities in the field of biochemical engineering, along with significant improvements in the healthcare infrastructure, especially in the developing nations, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global downstream processing market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technique, product, application and end use.
Breakup by Technique:
Breakup by Product:
Breakup by Application:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Boehringer Ingelheim International GmbH, Corning Corporation, Danaher Corporation, Eppendorf AG, Lonza Group AG, Merck KGaA, Repligen Corporation, Sartorius AG and Thermo Fisher Scientific Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Technique, Product, Application, End Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||3M Company, Boehringer Ingelheim International GmbH, Corning Corporation, Danaher Corporation, Eppendorf AG, Lonza Group AG, Merck KGaA, Repligen Corporation, Sartorius AG and Thermo Fisher Scientific Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Swine Healthcare Market by Product (Diagnostic Tests, Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), Route of Administration (Injectable, Oral), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy), and Region 2023-2028
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2023-2028
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Gastric Cancer Drugs Market by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at